We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

101 hedge funds and large institutions have $651M invested in Bicycle Therapeutics in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

57% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 23

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

19% more funds holding

Funds holding: 85 → 101 (+16)

7.54% more ownership

Funds ownership: 80.75% → 88.29% (+7.5%)

5% more capital invested

Capital invested by funds: $618M → $651M (+$32.8M)

47% less call options, than puts

Call options by funds: $2.04M | Put options by funds: $3.84M

Holders
101
Holders Change
+16
Holders Change %
+18.82%
% of All Funds
1.6%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
24
Increased
36
Reduced
23
Closed
7
Calls
$2.04M
Puts
$3.84M
Net Calls
-$1.8M
Net Calls Change
+$3.32M

Top Buyers

Rank Fund Capital Flow
1
PBA
Paradigm Biocapital Advisors
New York
+$37.9M
2
B
Braidwell
Connecticut
+$29.5M
3
SCM
Suvretta Capital Management
New York
+$23.1M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$18.8M
5
RCM
RA Capital Management
Massachusetts
+$18.3M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$13.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$8.47M
3
IC
Ikarian Capital
Texas
-$5.18M
4
SCM
Sio Capital Management
New York
-$3.93M
5
ECM
ExodusPoint Capital Management
New York
-$2.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
26
Platinum Investment Management
Australia
$5.74M +$6.53M +285,479 New
Fidelity Investments
27
Fidelity Investments
Massachusetts
$5.35M -$476K -20,800 -7%
RCMNY
28
Rubric Capital Management (New York)
New York
$4.13M – – –
BlackRock
29
BlackRock
New York
$3.9M +$297K +12,976 +7%
KCM
30
Kennedy Capital Management
Missouri
$3.15M +$766K +33,517 +27%
Citadel Advisors
31
Citadel Advisors
Florida
$2.73M +$561K +24,541 +22%
Handelsbanken Fonder
32
Handelsbanken Fonder
Sweden
$2.7M – – –
PHP
33
Parkman Healthcare Partners
Connecticut
$2.47M -$1.13M -49,564 -29%
DCM
34
DAFNA Capital Management
California
$2.45M – – –
VOYA Investment Management
35
VOYA Investment Management
Georgia
$2.28M +$571K +24,985 +28%
Deutsche Bank
36
Deutsche Bank
Germany
$1.94M +$2.01M +88,000 +1,051%
Legal & General Group
37
Legal & General Group
United Kingdom
$1.86M +$279K +12,207 +15%
HS
38
HighVista Strategies
Massachusetts
$1.86M – – –
Renaissance Technologies
39
Renaissance Technologies
New York
$1.65M +$254K +11,100 +16%
TD Asset Management
40
TD Asset Management
Ontario, Canada
$1.64M +$1.33M +58,200 +247%
Group One Trading
41
Group One Trading
Illinois
$1.63M -$62.7K -2,741 -3%
UOC
42
UBS O'Connor
Illinois
$1.57M – – –
TI
43
Trexquant Investment
Connecticut
$1.42M +$1.62M +70,719 New
Two Sigma Advisers
44
Two Sigma Advisers
New York
$1.42M -$1.57M -68,700 -49%
JP Morgan Chase
45
JP Morgan Chase
New York
$1.38M -$632K -27,652 -29%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$1.32M +$69K +3,017 +5%
CSS
47
Cubist Systematic Strategies
Connecticut
$1.32M +$934K +40,848 +165%
AA
48
AlphaCentric Advisors
Puerto Rico
$1.18M +$1.34M +58,500 New
SSA
49
Schonfeld Strategic Advisors
New York
$1.05M -$320K -14,000 -21%
GCM
50
Ghisallo Capital Management
Massachusetts
$1M +$1.14M +50,000 New
1
2
3 4 5

BCYC Hedge Fund Activity: Q3 2023 in Review

101 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q3 2023, worth a combined $651M — up 5.3% from $618M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BCYC positions and 7 closed out — a net gain of 17 holders — while 36 added to existing stakes and 23 trimmed.

The largest buyer was Paradigm Biocapital Advisors, adding an estimated $37.9M. The largest seller was Logos Global Management, exiting entirely with an estimated $13.3M sold.

  • 101 institutional investors held Bicycle Therapeutics (BCYC) as of Q3 2023, up from 85 in Q2 2023.
  • Funds reported $651M of Bicycle Therapeutics stock for Q3 2023, up 5.3% quarter-over-quarter.
  • 24 funds opened new Bicycle Therapeutics positions in Q3 2023 and 7 closed out, a net change of +17 holders.
  • The largest Bicycle Therapeutics buyer in Q3 2023 was Paradigm Biocapital Advisors, an estimated $37.9M added.
  • The largest Bicycle Therapeutics seller in Q3 2023 was Logos Global Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q3 2023.